Cytosorbents (CTSO) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Cytosorbents (CTSO) over the last 15 years, with Q3 2025 value amounting to 0.2.
- Cytosorbents' Equity Ratio fell 2829.93% to 0.2 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.2, marking a year-over-year decrease of 2829.93%. This contributed to the annual value of 0.23 for FY2024, which is 4712.23% down from last year.
- As of Q3 2025, Cytosorbents' Equity Ratio stood at 0.2, which was down 2829.93% from 0.24 recorded in Q2 2025.
- In the past 5 years, Cytosorbents' Equity Ratio registered a high of 0.88 during Q1 2021, and its lowest value of 0.2 during Q3 2025.
- In the last 5 years, Cytosorbents' Equity Ratio had a median value of 0.47 in 2023 and averaged 0.5.
- Per our database at Business Quant, Cytosorbents' Equity Ratio surged by 8326.16% in 2021 and then plummeted by 4712.23% in 2024.
- Quarter analysis of 5 years shows Cytosorbents' Equity Ratio stood at 0.7 in 2021, then dropped by 19.97% to 0.56 in 2022, then dropped by 20.74% to 0.44 in 2023, then plummeted by 47.12% to 0.23 in 2024, then dropped by 15.91% to 0.2 in 2025.
- Its Equity Ratio stands at 0.2 for Q3 2025, versus 0.24 for Q2 2025 and 0.29 for Q1 2025.